The DNA synthesis leader is pouring money into R&D and hoping it finds a sustainable business model. That's riskier than investors might realize."Twist Bioscience Delivers Steep Loss in Fiscal Q2 2019" via FOX BIZ https://fxn.ws/2LjJxaR
Subscribe to:
Post Comments (Atom)
Popular posts
-
This July, software grandee John McAfee donned the fool’s cap… and brought down roars of laughter upon his head… This bedlamite actuall...
-
Tesla drivers who engage the Autopilot feature should recognize that it requires the assistance of the driver, a cybersecurity expert told ...
No comments:
Post a Comment